OpenAlex
PricingAboutJobs
Log inGet started
Work

Treatment of Relapsed/Refractory Acute Myeloid Leukemia

HTML

Year: 2017
Type: review
Source: Current Treatment Options in Oncology
DOI: 10.1007/s11864-017-0456-2
Authors: Prithviraj Bose, Pankit Vachhani, Jorge E. Cortes
Institutions: The University of Texas MD Anderson Cancer Center, Roswell Park Comprehensive Cancer Center
Language: English

Topic: Acute Myeloid Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: relapsed/refractory acute myeloid leukemia, allogeneic hematopoietic stem cell transplantation, FLT3 inhibitors, IDH1/2 inhibitors, venetoclax, CPX-351, midostaurin, glasdegib, pracinostat, targeted therapy, actionable mutations, high-dose cytarabine, hypomethylating agents, elderly patients, clinical trials
SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute
Award: Cancer Center Support Grant
OpenAlex ID: W2593230508
FWCI: 4.48
Cites: 149
Cited by: 255
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security